Recent research from the National University of Singapore's Yong Loo Lin School of Medicine has turned conventional understanding of Polycystic Ovary Syndrome (PCOS) on its head, particularly for women in Singapore and broader Asia. Traditionally viewed as a barrier to fertility, PCOS appears to confer an unexpected advantage in reproductive longevity for many affected women, especially those with milder forms prevalent locally. This discovery, stemming from two landmark studies, highlights how Singaporean women with PCOS often maintain robust ovarian reserves well into their late 30s and beyond, achieving higher pregnancy success rates through assisted reproductive technologies compared to peers without the condition.

The findings challenge long-held fears around PCOS diagnosis, offering reassurance and paving the way for personalized care. Led by experts at NUS Medicine and the National University Hospital (NUH), these insights position PCOS not just as a challenge but potentially as a model for studying extended reproductive health—a timely revelation amid Singapore's low fertility rates and aging population.

Unpacking PCOS: A Common Yet Complex Condition

Polycystic Ovary Syndrome, or PCOS, is the most prevalent endocrine disorder among women of reproductive age, affecting an estimated 11% to 13% globally. In Singapore and Asia, prevalence mirrors this at around 10-15%, though diagnostic criteria and phenotypes vary. Defined by the 2003 Rotterdam criteria, PCOS requires at least two of three features: irregular ovulation or periods (oligo-ovulation/amenorrhea), clinical or biochemical hyperandrogenism (elevated male hormones leading to excess hair, acne), and polycystic ovarian morphology on ultrasound (multiple small follicles).

Symptoms extend beyond reproduction: metabolic risks like insulin resistance, type 2 diabetes, hypertension, and dyslipidemia are common, especially in obese subtypes. Yet, Asian women, including Singaporeans, often present 'leaner' PCOS with less hirsutism and obesity but persistent ovulatory issues. This ethnic nuance underscores why Western-centric views don't fully capture local realities, as NUS researchers emphasize.

In Singapore, where women delay childbearing—average first birth age now 31—understanding PCOS's local profile is crucial. Early diagnosis via blood tests (AMH for ovarian reserve, hormones) and ultrasound empowers proactive management.

The Game-Changing Subtypes Discovery

A pivotal Nature Medicine study, involving over 11,900 women primarily from China and validated in Singapore (127 women, 2011-2019), employed data-driven clustering to delineate four distinct PCOS subtypes, overturning the one-size-fits-all approach. Notably, Singapore boasts the highest rate of the 'SHBG-PCOS' subtype at 53%, versus 27% in China, 24% USA, 34% Europe, and 26% Brazil.

• SHBG-PCOS (High Sex Hormone-Binding Globulin): Mildest form; high SHBG binds excess androgens, low BMI, minimal metabolic risks. Best IVF success, lowest diabetes/hypertension incidence, highest remission potential.
• OB-PCOS (Overweight-Obesity): High BMI, insulin resistance; worst metabolic profile (e.g., 7.9% T2DM), lowest live births, but highest remission with lifestyle changes.
• HA-PCOS (Hyperandrogenic): Elevated testosterone/DHEA-S; hirsutism, miscarriage risks, dyslipidemia.
• LH-PCOS (Elevated LH/AMH): High LH, FSH, AMH; ovarian hyperstimulation risk in IVF, persistent symptoms.

Prof Yong Eu Leong, corresponding author and NUS Obstetrics & Gynaecology professor, notes: "This debunks the belief that PCOS is inherently worrying. Singapore's dominance of SHBG-PCOS explains favorable outcomes."

IVF Success: PCOS as Fertility Ally in Later Years

Complementing subtypes, a Human Reproduction Open study at NUH analyzed 1,249 IVF patients (2016-2022), 212 with PCOS. Key metric: Anti-Müllerian Hormone (AMH), gauging ovarian reserve. PCOS women averaged 44.4 pmol/L vs 19.3 in controls, with slower age-related decline—sustaining high levels past 36.

Cumulative pregnancy rates: 52.8% PCOS vs 38.7% non-PCOS overall; strikingly, at ≥36 years, 55.9% vs 28.6% (adjusted RR 1.78-2.01). Oocytes retrieved: nearly double (higher blastocysts, fertilized eggs). Adjunct Asst Prof Huang Zhongwei, lead and ACRLE deputy director, states: "PCOS women maintain egg supply with age, excelling in ART even later— a longevity model."

Real cases: Ms Andrea Lee (40) credited large egg pool for conception at 38; Ms Ke Youduan (48) conceived naturally multiple times asymptomatically.

For deeper dive, see the full study.

Photo by Roman Kraft on Unsplash

Why Singaporean Women? Ethnic and Lifestyle Factors

Asia's PCOS phenotype differs: less androgen excess, more anovulation-driven, leaner builds. Singapore's multi-ethnic mix (Chinese-majority) aligns with high-SHBG, low-BMI subtype. Lower obesity rates (vs West) mitigate metabolic woes. Lifestyle—active urban living, diet—may enhance outcomes, per NUS analyses showing BMI's outsized role.

Yet challenges persist: undiagnosis (up to 70% globally), stigma. Singapore's advanced healthcare (NUH fertility clinics) facilitates early intervention.

NUS Medicine's Vanguard Role in Reproductive Research

At NUS Yong Loo Lin School, the Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE) drives this work, focusing Asian women's reproductive healthspan. Prof Yong and Dr Huang exemplify clinician-scientists bridging lab-clinic. ACRLE integrates digital health, genomics for longevity insights—PCOS as exemplar.

Health Implications Beyond Fertility

While reproductive perks shine, metabolic vigilance key. SHBG-PCOS: lowest risks; OB-PCOS: prioritize weight management (5-10% loss restores ovulation). Long-term: PCOS raises endometrial cancer, CVD odds—mitigated by screening, metformin, lifestyle. Singapore guidelines echo international: holistic—diet (low-GI), exercise (150min/week), OCPs for cycles/androgens.

Explore NUH's PCOS resources.

Personalized Pathways: Tailoring Treatment in Singapore

Subtypes enable precision: SHBG-PCOS—ovulation induction; OB—weight loss first (orlistat/GLP-1s emerging); HA—anti-androgens; LH—careful IVF stimulation. NUH/NUS clinics offer multidisciplinary care: endocrinologists, dietitians, psychologists. Success stories abound, with 70%+ pregnancy at 36+ in PCOS cohort.

Photo by Albert Vincent Wu on Unsplash

• Step 1: Diagnosis (ultrasound, hormones, exclude mimics).
• Step 2: Subtype assessment (SHBG, BMI, LH/AMH).
• Step 3: Lifestyle (Mediterranean diet, HIIT).
• Step 4: Meds/ART as needed.

Societal Impact: Boosting Singapore's Fertility Landscape

Amid TFR 1.0, PCOS insights empower delayed motherhood. Policymakers eye incentives; NUS research informs. Broader: destigmatizes PCOS, promotes screening. Straits Times coverage amplified reach. Read full ST article.

Future Horizons: From NUS Labs to Global Guidelines

NUS pioneers longitudinal PCOS tracking, genetics, interventions. Prof Choolani: "Personalized care transforms lives." Trials test longevity mechanisms (follicle dynamics). For Singapore women: optimism, action—consult early, live fully.